Projects per year
Organization profile
Organisation profile
This doctoral research program was established in collaboration with Academia Sinica to cultivate interdisciplinary research that focuses on tumor-related medicine. Academia Sinica is Taiwan’s leading research institute and has outstanding scientific researchers and cutting-edge equipment for advanced research. TMU also works in collaboration with its three affiliated hospitals and has access to their clinical resources.
Through these relationships, the Cancer Biology and Drug Discovery program offers students a great opportunity to build a career with excellent research support. We enroll top students from around the world, and provide a strong curriculum of interdisciplinary training as well as a learning environment where students work with many research specialists.
From basic research to translational medicine, we develop cutting-edge therapeutic strategies for cancer prevention and treatment. We work hard for cancer patients, seeking to extend their lives and improve their quality of life.
Fingerprint Dive into the research topics where Ph.D. Program for Cancer Molecular Biology and Drug Discovery is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects
第3期癌症研究癌症整合研究計畫-以α9-尼古丁受體作為分子標靶探討國人乳癌發生之風險暴露及抗體藥物研發與臨床前試驗評估(第3年)
1/1/20 → 12/31/20
Project: A - Government Institution › c - Ministry of Health and Welfare
使用一步驟原位固態合成法製備助催化劑/氧化釩鉍觸媒應用於光電化學水分解系統
1/1/20 → 12/31/20
Project: C - Project of Alliance › i - National Taipei University of Technology
探討ZBTB46在神經內分泌前列腺癌抗藥性之分子機轉及治療研究
1/1/20 → 12/31/20
Project: A - Government Institution › a - National Health Research Institutes
Research Output
Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))
Lin, C. F., Huang, H. L., Peng, C. Y., Lee, Y. C., Wang, H. P., Teng, C. M. & Pan, S. L., Jan 15 2020, In : Toxicology and Applied Pharmacology. 387, 114858.Research output: Contribution to journal › Comment/debate
Open Access
Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer
Chen, C. H., Hsieh, Y. C., Yang, P. M., Liu, Y. R. & Cho, E. C., 2020, In : Biochemical and Biophysical Research Communications.Research output: Contribution to journal › Article
Evaluation of machine learning methods to stroke outcome prediction using a nationwide disease registry
Lin, C. H., Hsu, K. C., Johnson, K. R., Fann, Y. C., Tsai, C. H., Sun, Y., Lien, L. M., Chang, W. L., Chen, P. L., Lin, C. L. & Hsu, C. Y., Jul 2020, In : Computer Methods and Programs in Biomedicine. 190, 105381.Research output: Contribution to journal › Article